stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Royalty Pharma PlcRPRX
$68.680.23%0.155

Royalty Pharma Plc (RPRX)

Royalty Pharma Plc stock is traded at $68.68, with a volume of 2,622,511. It is up +0.23% in the last 24 hours and up +12.66% over the past month. Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
Previous Close:
$68.53
Open:
$67.92
24h Volume:
2,622,511
Relative Volume:
0.72
Market Cap:
$30.58B
Revenue:
$2.44B
Net Income/Loss:
$1.36B
P/E Ratio:
35.97
EPS:
$1.91
Net Cash Flow:
$574.14M
1W Performance:
-1.11%
1M Performance:
+12.66%
6M Performance:
+29.95%
1Y Performance:
+75.38%
1-Day Range:
$67.62$68.77
1-Week Range:
$67.62$70.37
52-Week Range:
$37.31$70.37

Royalty Pharma Plc Stock (RPRX) Company Profile

Name
Royalty Pharma Plc
Phone
(212) 883-0200
Address
110 EAST 59TH STREET, NEW YORK, NY, USA
Employee
100
X
-
Next Earnings Date
-
Latest SEC Filings
SEC
RPRX's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Royalty Pharma Plc Stock (RPRX) Financials Data

Similar to RPRX